revised syllabus pharmacology
TRANSCRIPT
-
8/10/2019 Revised Syllabus Pharmacology
1/15
1
DOA REMEDIOS T. ROMUALDEZ MEDICAL FOUNDATIONTACLOBAN CITY
COLLEGE OF NURSING
PHARMACOLOGY ( PETITION)
COURSE DESCRIPTION: This course deals with pharmacodynamics, pharmacokinetics,
clinical/therapeutic uses and toxicology of drugs. Emphasis is given on how a
drug works to anticipate when giving a drug to a patient are of paramount
importance since nursing responsibilities include administering drugs, calculating
medication dosages based on given setting, assessing drug effects, intervening to make a
drug more tolerable, and providing teaching about drugs and the drug regimen.
COURSE CREDIT: 3 UNITS LECTURE
CONTACT HOURS/ SEM: 54 LECTURE HOURS
PREREQUISITE: Math 1 Basic Mathematics, General Chemistry, Anatomy and Physiology, NCM 102
Fundamentals of Nursing
PLACEMENT: 2ND YEAR, 2ND SEMESTER
TERMINAL COMPETENCY: At the end of the course and given relevant actual or simulated
situations/conditions, the student will be able to:
1.
Apply concept and principles of pharmacology to ensure safe and proper use of
drugs
2.
Explain the action, therapeutic use, preparation, dosage, mode ofadministration of selected drugs and medicinal plants
3.
State precautionary measures to be observed in the administration of selected
drugs
4.
Discuss the role and responsibility of the nurse in pharmacology
5.
Interpret medication orders.
6.
Calculate medication orders based on the given setting.
INTERMEDIATE COMPETENCIES CONTENT DATE/TIME
INSTRUCTOR
Upon completion of this chapter,the students will be able to:
1.
Define the word
pharmacology.
2.
Outline the steps
involved in developing
and approving a new
drug in the United States.
3.
Describe the federal
controls on drugs that
have abuse potential.
4.
Differentiate between
generic and brand-name
drugs, over-the-counter
and prescription drugs
5.
Explain the benefits and
risks associated with the
use of over-the-counter
drugs.
I. INTRODUCTION TO PHARMACOLOGY
1. Pharmacology
2. Pharmacology and Therapeutics
3. Classification of therapeutic Agents as
Drugs, Biologics, and alternative
Therapies
4. Prescription and Over the Counter
Drugs
5. Drug Regulations and Standards
6. Sources and Evaluation of Drugs
7. Legal Regulation of Drugs
8. Drug Classes and Schedules
A. DRUG AND THE BODY
1. Pharmacokinetics
2. Pharmacodynamics
3. Factors Influencing Drug Effects
B. TOXIC EFFECTS OF DRUGS
1. Adverse Effects
June26*
1:30 -
3:00
4:30
6:00
June
27
1:30 -
3:00
MRS. ALFONSO
MRS. ALFONSO
-
8/10/2019 Revised Syllabus Pharmacology
2/15
2
INTERMEDIATE COMPETENCIES CONTENT DATE/TIME
INSTRUCTOR
Upon completion of this chapter,
the students will be able to:
1.
List the responsibilities of
the nurse in drugtherapy.
2.
Explain what is involved
in each step of the
nursing process as it
relates to drug therapy.
3.
Describe key points that
must be incorporated
into the assessment of a
patient receiving drug
therapy.
4.
Describe the essential
elements of a medication
order.
5.
Calculate the correct
dose of a drug when
given examples of drug
orders and available
forms of the drugsordered.
6.
Outline the important
points that must be
assessed and considered
before administering a
drug, combining
knowledge about the
drug with knowledge of
the patient and theenvironment.
7.
Describe the role of the
nurse and the patient in
preventing medication
errors.
2. Drug Allergy
3. Drug-Induced Tissue and Organ
Damage
C. NURSING MANAGEMENT
THE NURSING PROCESS
a. ASSESSMENT
Subjective data
a. History
- Health History Assessment Questions
Pertinent to Drug Administration
Objective Data
a. Physical Assessment
b. Laboratory Values
c. Medication Effects
b. NURSING DIAGNOSIS
c. PLANNING
d. IMPLEMENTATION
- Principles of Drug Administration
- Proper Drug Administration
- Comfort Measures
- Patient and Family Education
e. EVALUATION
D. DOSAGE CALCULATIONS
E. DRUG ADMINISTRATION THROUGHOUT
THE LIFESPAN
PHARMACOTHERAPY ACROSS THE LIFESPAN
1. PREGNANT CLIENT
2. LACTATING CLIENT
3. PEDIATRICS
4. ADULTHOOD
F. MEDICATION ERRORS AND RISKREDUCTION
1. Medication Errors
July 3
1:30 -
3:00
July 4
1:30 -
3:00
MR. NICOLAS
MRS. ALFONSO
-
8/10/2019 Revised Syllabus Pharmacology
3/15
3INTERMEDIATE COMPETENCIES CONTENT DATE/TIME INSTRUCTOR
Upon completion of this chapter,
the students will be able to:
1. List four natural body
defenses against
infection.
2. Describe the cells
associated with thebodys fight against
infection and their basic
functions.
3. Outline the sequence
of events in the
inflammatory response.
4. Correlate the events in
the inflammatory
response with the clinical
picture of inflammation.
5. Outline the sequence
of events in an antibody-
related immune reaction
and correlate these
events with the clinical
presentation of such a
reaction.
6.
Describe the sites of
action of the various anti-
inflammatory agents.
7.
Describe the therapeutic
actions, indications,pharmacokinetics,
contraindications, most
common
8.
adverse reactions, and
important drugdrug
interactions associated
with each class of
anti-inflammatory
agents.
9.
Discuss the use of anti-
inflammatory drugs
across the lifespan.
10.
Compare and contrast
the prototype drugs for
each class of anti-
inflammatory drugs with
the other drugs in that
class.
11.
Outline the nursing
considerations and
teaching needs for
patients receiving each
class of antiinflammatoryagents.
II. CONCEPT OF IMMUNOLOGY ANDINFLAMMATORY PROCESSES
THE IMMUNE SYSTEM
- Nonspecific Body Defenses and
Immune Responses
- Humoral Immunity and Antibodies- Cell mediated Immunity and Cytokines
- Nursing Process
A. IMMUNE SYSTEM MODULATORS
1. Vaccines
2. Immunostimulants
3. Immunosuppresants
CONCEPT ON INFLAMMATION
- Function of Inflammation
- Role of Histamine in Inflammation
- Histamine Receptors
- Nursing Process
B. ANTIINFLAMMATORY AGENTS
1. Nonsteroidal anti-inflammatory drugs
2. Systemic Glucocorticoids3. Antipyretics
- Mechanism of Action
- Therapeutic actions and indication
- Pharmacokinetics
- Contraindications and Cautions
- Adverse Effects
- Clinically important drug-drug
interaction
- Nursing Process
- Patient Teaching List
a. NSAIDS
JULY 10
1: 303:00
July 11*
1:303:00
4:306:00
MR. NICOLAS
MR. NICOLAS
INTERMEDIATE COMPETENCIES CONTENT DATE/TIME INSTRUCTOR
Upon completion of this chapter, C. ANTIINFECTIVE AGENTS
-
8/10/2019 Revised Syllabus Pharmacology
4/15
4
the students will be able to:
1. Explain what is meant
by selective toxicity and
discuss its importance in
anti-infective therapies.
2. Differentiate betweenbroad-spectrum and
narrow-spectrum drugs.
3. Define bacterial
resistance to antibiotics
and discuss the
emergence of resistant
strains.
4. Explain three ways to
minimize bacterial
resistance.
5. Describe three
common adverse
reactions associated with
the use of antibiotics
6.
Explain how an antibiotic
is selected for use in a
particular clinical
situation.
7.
Describe therapeutic
actions, indications,
pharmacokinetics,
contraindications, mostcommon adverse
reactions, and important
drugdrug interactions
associated with each of
the classes of antibiotics.
8.
Discuss use of antibiotics
as they are used across
the lifespan.
9.
Compare and contrast
prototype drugs for each
class of antibiotics withother drugs in that class.
10.
Outline nursing
considerations for
patients receiving each
class of antibiotic.
1. Pathogenenicity and Virulence
2. Description and Classification of
Bacteria
3. Antiinfective Drugs
4. Acquired Resistance
5. Selection of effective antibiotics6. Host Factors
Mechanism of Action
- Therapeutic actions and indication
- Pharmacokinetics
- Contraindications and Cautions
- Adverse Effects
- Clinically important drug-drug
interaction
- Nursing Process
- Patient Teaching List
7. Antibacterial Agents
- Penicillins
- Cephalosporins
- Tetracyclines
- Macrolides
- Aminoglycosides
- Fluoroquinolones- Sulfonamides
- Antituberculosis Agents
Mechanism of Action
- Therapeutic actions and indication
- Pharmacokinetics
- Contraindications and Cautions
- Adverse Effects
- Clinically important drug-drug
interaction
- Nursing Process- Patient Teaching List
INTERMEDIATE COMPETENCIES CONTENT DATE/TIME INSTRUCTOR
Upon completion of this chapter,
you will be able to:
D. ANTIVIRAL AGENTS July 17 MR. NICOLAS
-
8/10/2019 Revised Syllabus Pharmacology
5/15
5
1.
Discuss problems with
treating viral infections
in humans and the use
of antivirals across the
lifespan.
2.
Describe the therapeuticactions, indications,
pharmacokinetics,
contraindications, most
common adverse
reactions, and important
drugdrug interactions
associated with each of
the types of antivirals
discussed in the chapter.
3.
Compare and contrast
the prototype drugs for
each type of antiviral
with the other drugs
within that group.
4.
Outline the nursing
considerations for
patients receiving each
class of antiviral agent.
5.
Describe the
characteristics of a
fungus and a fungalinfection.
6.
2. Discuss the
therapeutic actions,
indications,
pharmacokinetics,
contraindications,
proper administration,
most common adverse
reactions, and important
drugdrug interactions
associated with systemicand topical antifungals.
7.
Compare and contrast
the prototype drugs for
systemic and topical
antifungals with the
other drugs in each
class.
8.
Discuss the impact of
using antifungals across
the lifespan.
9.
Outline the nursing
considerations for
patients receiving a
systemic or topical
antifungal.
1. Characteristics of Viruses
2. HIV/AIDS
3. General Principles of HIV
Pharmacotherapy
4. Classification of Drugs for HIV/ AIDS
- Reverse Transcriptase Inhibitors
- Protease Inhibitors5. Pharmacotherapy
a. Herpes Virus Infections
b. Influenza
c. Viral Hepatitis
Mechanism of Action
- Therapeutic actions and indication
- Pharmacokinetics
- Contraindications and Cautions
- Adverse Effects
- Clinically important drug-drug
interaction
- Nursing Process
- Patient Teaching List
E. ANTIFUNGAL AGENTS
1. Characteristics of Fungi
2. Classifications of Mycoses3. Mechanism of Action
4. Nursing Process
5. Antifungal Agents
- Systemic
- Superficial
Mechanism of Action
- Therapeutic actions and indication
- Pharmacokinetics
- Contraindications and Cautions
- Adverse Effects- Clinically important drug-drug
interaction
- Nursing Process
- Patient Teaching List
1:303:00
INTERMEDIATE COMPETENCIES CONTENT DATE/TIME INSTRUCTOR
Upon completion of this chapter, F. ANTIPROTOZOAL AGENTS July 18 MR. NICOLAS
-
8/10/2019 Revised Syllabus Pharmacology
6/15
6
the students will be able to:
1.
Outline the life cycle of
the protozoan that
causes malaria.
2.
Describe the therapeutic
actions, indications,pharmacokinetics,
contraindications,
proper administration,
most common adverse
reactions, and important
drugdrug interactions
associated with drugs
used to treat malaria.
3.
Describe other common
protozoal infections,
including cause and
clinical presentation.
4.
Compare and contrast
the antimalarials with
other drugs used to treat
protozoal infections.
5.
Outline the nursing
considerations for
patients receiving an
antiprotozoal agent
across the lifespan
6.
Describe the therapeutic
actions, indications,
pharmacokinetics,
contraindications, most
common adverse
reactions, and important
drugdrug interactions
associated with the
anthelmintics and
antineoplastic drugs.
7.
Discuss the use ofanthelmintics and
antineoplastic drugs
across the lifespan.
8.
Outline the nursing
considerations, including
important teaching
points to stress, for
patients receiving an
anthelmintic and
antineoplastic drugs.
a. Malarial Drugs
b. Nonmalarial Drugs
Mechanism of Action
- Therapeutic actions and indication
- Pharmacokinetics
- Contraindications and Cautions- Adverse Effects
- Clinically important drug-drug
interaction
- Nursing Process
- Patient Teaching List
G. ANTIHELMINTIC DRUGS
H. ANTINEOPLASTIC AGENTS
1. Characteristic of Cancer: Uncontrolled
Cell Growth
2. Causes of Cancer
3. Treatment of Cancer
4. Growth Fraction and Success of
Chemotherapy
5. Special Pharmacotherapy Protocols
and Strategies for Cancer Chemotherapy
6. Toxicity of Antineoplastic Agents7. Classification of Antineoplastic Agents
Mechanism of Action
- Therapeutic actions and indication
- Pharmacokinetics
- Contraindications and Cautions
- Adverse Effects
- Clinically important drug-drug
interaction
- Nursing Process
- Patient Teaching List
1:303:00
INTERMEDIATE COMPETENCIES CONTENT DATE/TIME INSTRUCTOR
-
8/10/2019 Revised Syllabus Pharmacology
7/15
7
Upon completion of this chapter,
the students will be able to:
1.
Describe the anatomy
and physiology of the GI
system.
2.
Describe thepathophysiology of
Peptic Ulcer Disease.
3.
Describe the therapeutic
actions, indications,
pharmacokinetics,
contraindications and
cautions, most common
adverse reactions, and
important drugdrug
interactions associated
with laxatives,
antidiarrheal drugs,
antispasmodics and
antiemetics
4.
Discuss the use of
laxatives, antidiarrheal
drugs, antispasmodics
and antiemetics
across the lifespan.
5.
Outline the nursing
considerations, including
important teaching
points to stress, forpatients receiving an
laxatives, antidiarrheal
drugs, antispasmodics
and antiemetics drugs.
Upon completion of this chapter,
the students will be able to:
1.
Label a diagram showing
the glands of the
traditional endocrinesystem and list the
hormones produced by
each and its functions
2.
Describe the
pathophysiology of
diabetes mellitus,
including alterations in
metabolic pathways and
changes to basement
membranes.
3.
Describe the therapeutic
actions, indications,
pharmacokinetics,
contraindications, most
common adverse
reactions, and important
drugdrug interactions
III. CONCEPT ON METABOLIMFUNCTIONAL HEALTH PATTERN
NUTRITION AND METABOLIC PATTERN
1. Overviewa. GI System
b. Acid Production by the stomach
c. Peptic Ulcer Disease
2. Drug Therapy
a. Antiulcer Drugs
b. Laxatives
c. Antispasmodics
d. Antiemetics
Mechanism of Action
- Therapeutic actions and indication
- Pharmacokinetics
- Contraindications and Cautions
- Adverse Effects
- Clinically important drug-drug
interaction
- Nursing Process
- Patient Teaching List
IV. THE ENDOCRINE SYSTEM ANDHOMEOSTASIS
a. Drugs acting on the Endocrine System
- Hypothalamic and Pituitary Agents
- Hypothalamic Releasing Agents
- Anterior Pituitary Hormones
b. Drug Therapy
- Growth Hormone
- Growth Hormone Antagonist- Posterior Pituitary Hormones
- Adrenocortical Agents
- Thyroid and Parathyroid Hormones
- Antidiabetic Agents
a. Glucose regulation
b. Diabetes Mellitus
c. Drug Therapy
- Insulin
- Oral Antidiabetic Agents
Mechanism of Action
- Therapeutic actions and indication
- Pharmacokinetics
- Contraindications and Cautions
- Adverse Effects
- Clinically important drug-drug
interaction
- Nursing Process
- Patient Teaching List
July 24*
1:303:00
4:306:00
July 25
1:303:00
July 31
1:303:00
August 1
1:303:00
MRS. ALFONSO
MRS. ALFONSO
MR. NICOLAS
MR. NICOLAS
INTERMEDIATE COMPETENCIES CONTENT DATE/TIME INSTRUCTOR
-
8/10/2019 Revised Syllabus Pharmacology
8/15
8
associated with insulin and other
antidiabetic and glucose-
elevating agents.
Upon completion of this chapter,
the students will be able to:
1.
Review the anatomy andphysiology of the kidney,
including the structure
of the nephron
2.
Describe the
pathophysiology of
Renal failure and other
renal pathology.
3.
Describe the therapeutic
actions, indications,
pharmacokinetics,
contraindications and
cautions, most common
adverse reactions, and
important drugdrug
interactions associated
with the various classes
of diuretic drugs and
other urinary tract
agents.
4.
Outline the nursing
considerations, including
important teaching
points to stress, forpatients receiving
diuretic drugs and other
urinary tract agents .
Upon completion of this chapter,
the students will be able to:
1.
Review the anatomy
and physiology of
nervous system.
2.
2. Describe the
therapeutic actions,
indications,
pharmacokinetics,
contraindications and
cautions, most common
adverse reactions, and
important drugdrug
interactions associated
with the various classes
of drugs affecting the
nervous system.
V. CONCEPT OF FLUID ANDELECTROLYTES FUNCTIONAL HEALTH
PATTERN
ELIMINATION PATTERN
1. Overview of the Renal System
a. Renal absorption and Secretion
b. Fluid and Elctrolyte Balance
c. Renal Failure
2. Drug Acting on the Renal System
a. Diuretics
b. Urinary Tract Agents
c. Parenteral Fluids and Electrolytes
Mechanism of Action
- Therapeutic actions and indication
- Pharmacokinetics
- Contraindications and Cautions
- Adverse Effects
- Clinically important drug-drug
interaction
- Nursing Process
- Patient Teaching List
VI. CONCEPT ON PERCEPTION ANDCOORDINATION
THE NERVOUS SYSTEM
a. Central Nervous System
b. Peripheral Nervous System
b.1 Autonomic Nervous System- Sympathetic
- Paraympathetic
A. DRUGS AFFECTING THE ANS
a. Adrenergic Agents
b. Adrenergic Blocking Agents
c. Cholinergic Agents
d. Cholinergic Blocking Agents
Aug 7
1:303:00
August 8
1:303:00
Aug. 14*
1:303:00
4:30- 6:00
MRS. ALFONSO
MRS. ALFONSO
MRS. ALFONSO
-
8/10/2019 Revised Syllabus Pharmacology
9/15
9INTERMEDIATE COMPETENCIES CONTENT DATE/TIME INSTRUCTOR
3. Outline the nursing
considerations, including
B. DRUGS ACTING ON THE CNS AND PNS
A. ANXIOLYTICS AND HYPNOTIC AGENTS
August 15
1:30- 3:00
MRS. ALFONSO
-
8/10/2019 Revised Syllabus Pharmacology
10/15
10
important teaching points, for
patients receiving
and adrenergic agent.
Upon completion of this chapter,
the students will be able to:
1.
Describe the therapeutic
actions, indications,
pharmacokinetics,
contraindications and
cautions, most common
adverse reactions, and
important drugdrug
interactions associated
with the various classes
of psychotherapeutic
and antiepileptic agents.
2.
Outline the nursing
considerations, including
important teaching
points, for patients
receiving
psychotherapeutic and
antiepileptic drugs
Upon completion of this chapter,
the students will be able to:
1.
Describe the therapeuticactions, indications,
pharmacokinetics,
contraindications, most
common adverse
reactions, and important
drugdrug interactions
associated with
antiparkinsonism and
muscle relaxant drugs.
1. States affected by anxiolytic and
hypnotic drugs
2. Drug Therapy
a. Benzodiazepines
- Antidote
b. Barbiturates
MIDTERM EXAMINATION
B. ANTIDEPRESSANT DRUGS
1. Depression and Antidepressant
2. Drug Therapy
3. Tricyclic Depressants
4. MAOIs
5. SSRIs
C. PYCHOTHERAPEUTIC AGENTS
1. Mental Disorders and their
Classification
2. Psychotherapeutic Drugs
a. Antipsychotic Neuroleptic Drugs
b. Antimanic Drugs
c. CNS Stimulants
D. ANTIEPILEPTIC DRUGS
1. Nature of Epilepsy
2. Drugs for treating Tonic-Clonic
Seizures3. Drugs for Treating Absence Seizures
Mechanism of Action
- Therapeutic actions and indication
- Pharmacokinetics
- Contraindications and Cautions
- Adverse Effects
- Clinically important drug-drug
interaction
- Nursing Process
- Patient Teaching List
DEGENERATIVE DISEASES OF THE CENTRALNERVOUS SYSTEM
E. ANTIPARKINSONISM AGENTS
1. Parkinsonism
2. Drug Therapy
a. Anticholinergics
b. Dopaminergics
- Adjuncts to Levodopa Therapy
August 18-
23
Aug 28*
1:30- 3:00
4:306:00
August 29
1:30- 3:00
Sept 4
1:303:00
MR. NICOLAS
MR. NICOLAS
MRS. ALFONSO
INTERMEDIATE COMPETENCIES CONTENT DATE/TIME INSTRUCTOR
2.
Discuss the use of
antiparkinsonism and
F. MUSCLE RELAXANTS
1. Nerves and Movements
-
8/10/2019 Revised Syllabus Pharmacology
11/15
11
muscle relaxant drugs
across the lifespan.
3.
Outline the nursing
considerations, including
important teaching
points to stress, forpatients receiving an
antiparkinsonism and
muscle relaxant drugs.
Upon completion of this chapter,
the students will be able to:
1.
Describe the therapeutic
actions, indications,
pharmacokinetics,
contraindications, most
common adverse
reactions, and important
drugdrug interactions
associated with
narcotics, antimigraine
and general and localanesthetic and
neuromuscular drugs.
2.
Discuss the use of
narcotics, antimigraine
and general and local
anesthetic and
neuromuscular drugs
across the lifespan.
3.
Outline the nursing
considerations, including
important teachingpoints to stress, for
patients receiving an
narcotics, antimigraine
and general and local
anesthetic and
neuromuscular drugs.
2. Neuromuscular Abnormalities
3. Drug Therapy
- Centrally Acting Skeletal Muscle
Relaxants
- Direct Acting Skeletal Antispasmodic
Mechanism of Action- Therapeutic actions and indication
- Pharmacokinetics
- Contraindications and Cautions
- Adverse Effects
- Clinically important drug-drug
interaction
- Nursing Process
- Patient Teaching List
G. NARCOTICS AND ANTIMIGRAINE
DRUGS
1. Pain Perception
2. Migraine Headache
3. Drug Therapy
a. Narcotics
b. Opiod Receptors
c. Narcotic Agonists
d. Narcotic Agonist Antagonist
e. Narcotic Antagonist
f. Ergot Derivatives
g. Triptans
H. GENERAL AND LOCAL ANESTHETICS
1. Local Anesthesia
2. General Anesthesia
3. Drug Therapy
I. NEUROMUSCULAR AGENTS
1. Neuromuscular Junction
2. Drug Therapy
a. Nondepolarizing Neuromuscular
Junction Blockers
b. Depolarizing Neuromuscular JunctionBlockers
Sept 5
1:30 -3:00
Sept 11
1:30- 3:00
Sept 12
1:303:00
MRS. ALFONSO
MRS. ALFONSO
MR. NICOLAS
INTERMEDIATE COMPETENCIES CONTENT DATE/TIME INSTRUCTOR
Upon completion of this chapter,
the students will be able to: VII. CONCEPTS ON OXYGENATION, Sept 18 MR. NICOLAS
-
8/10/2019 Revised Syllabus Pharmacology
12/15
12
1.
Review the anatomy and
physiology of
cardiovascular system.
2.
Describe the
pathophysiology of
hypertension.
3.
Describe the therapeuticactions, indications,
pharmacokinetics,
contraindications, most
common adverse
reactions, and important
drugdrug interactions
associated with
antihypertensive drugs.
4.
Outline the nursing
considerations in using
antihypertensive drugs.
5.
Describe the
pathophysiology of
cardiac arrhythmias and
angina.6.
Describe the therapeutic
actions, indications,
pharmacokinetics,
contraindications, most
common adverse
reactions, and important
drugdrug interactions
associated with
antiarrhythmic and
antianginal drugs.
7.
Outline the nursingconsiderations in using
antiarrhythmic and
antianginal drugs
PERFUSION FUNCTIONAL HEALTH PATTERN
A.
DRUGS ACTING ON THE
CARDIOVASCULAR SYSTEM
1.
Overview : Cardiovascular System
2.
ANTIHYPERTENSION
a. Renin-Angiotensin System
b. Blood Pressure Control
c. Hormonal and Nervous System
Factors Influencing Blood Pressure
d. Primary Factors affecting BP
e. Drug Therapy
A. ANTIHYPERTENSIVE DRUGS
1. ACE Inhibitors
2. Angiotensin II Receptor Blocker
3. Calcium Channel Blockers
4. Vasodilators
5. Diuretics
6. Beta Blockers
7. Hypotensive Agents
B. ANTIARRHYTHMIC AGENTS
1. Overview
a. Cardiac Conductionb. Automaticity of the heart
c. Cardiac Arrhythmias
2. Drug Therapy
a. Class I: Sodium Channel Blockers
b. Class II : Beta Adrenergic Antagonist
c. Class III: Potassium Channel Blockers
d. Class IV: Calcium Channel Blockers
C. ANTIANGINAL AGENTS
1. Overviewa. Blood Supply to Myocardium
b. Coronary Artery Disease
2. Drug Therapy
a. Nitrates
b. Beta-Adrenergic Blockers
c. Calcium Channel Blockers
1:30- 3:00
Sept 19
1:303:00
MR. NICOLAS
INTERMEDIATE COMPETENCIES CONTENT DATE/TIME INSTRUCTOR
Upon completion of this chapter, Sept. 26 MRS. ALFONSO
-
8/10/2019 Revised Syllabus Pharmacology
13/15
13
the students will be able to:
1.
Describe the
pathophysiology of
congestive heart failure
and coronary artery
disease.
2.
Describe the therapeuticactions, indications,
pharmacokinetics,
contraindications, most
common adverse
reactions, and important
drugdrug interactions
associated with
cardiotonic and lipid
lowering agents.
3.
Outline the nursing
considerations in using
cardiotonic and lipid
lowering agents.
4.
Describe the coagulation
process.
5.
Describe the
pathophysiology of
anemia.
6.
Describe the therapeuticactions, indications,
pharmacokinetics,
contraindications, most
common adverse
reactions, and important
drugdrug interactions
associated with drugs
affecting blood
coagulation and
antianemic agents.
7.
Outline the nursingconsiderations in using
drugs affecting blood
coagulation and
antianemic agents
D. CARDIOTONIC AGENTS
1. Overview
a. Cardiac Muscle Function
b. Congestive Heart Failure
2. Drug Therapy
a. Vasodilatorsb. Diuretics
c. Beta-Adrenergic Agonists
d. Cardiotonic Agents
- Cardiac Glycosides
e. Phophodiesterase Inhibitors
E. LIPID LOWERING AGENTS
1. Overview
a. Metabolism of Fats
b. Coronary Artery Disease
2. Drug Therapy
a. HMG-COA Reductase Inhibitors
b. Bile Acid Binding Agents
c. Fibric Acid Agents
d. Other Agents
F. DRUG AFFECTING BLOOD
COAGULATION
1. Overview
a. Blood Coagulation
b. Clot Resolution and Anticlotting
2. Drug Therapy: Hematopietic Growth
Factor
a. Epoetin Alfa
b. Colony Stimulating Factor
c. Platelet Enhancers
- Vitamin K: Reversing Warfarin Effects
- Protamine Sulfate: Antidote for
Heparin Overdose
- Lepirudin: Treating Heparin Allergy
G. DRUGS USED TO TREAT ANEMIA
1. Overview
a. Blood Components
b. Erythropoiesis
c. Anemia
2. Drug Therapy
a. Iron Supplement
1:303:00
Oct. 2
1:303:00
Oct 3
1:303:00
Oct 9
1:303:00
MRS. ALFONSO
MR. NICOLAS
MR. NICOLAS
INTERMEDIATE COMPETENCIES CONTENT DATE/TIME INSTRUCTOR
Upon completion of this chapter,
the students will be able to:
H. DRUG AFFECTING THE RESPIRATORYSYSTEM
Oct. 10
1:303:00
MRS. ALFONSO
-
8/10/2019 Revised Syllabus Pharmacology
14/15
14
TOTAL OF 54 hrs( 3hrs per week except those where * ( Thursdays: 1:303:00 and 4:306:00 pm) is indicated tocomplete the total number of hours [ 54hours] in 18 weeks. )
SCHEDULE:
LECTURE DAYS: MRS.LOURADEL U. ALFONSO/ MR. HERMAN NICOLAS
THURDAYS: 1: 303: 00 pm * ( 4:306:00 pm)
FRIDAYS: 1: 303 :00 pm
REFERENCES:
1. Karch, A,. Focus on Nursing Pharmacology. 6thEd.
2. Kee, Joyce, E. Hayes, L. McCuistion, Pharmacology: A Nursing Process Approach. 7thEd.
3. Clayton, Bruce and Y. Stock, Basic Pharmacology for Nurses. 16thEd.
4. Linda Skidmore-Roth RN MSN NP. Mosby's 2014 Nursing Drug Reference. 27thEd.
5. Richard A. Lehne. Pharmacology for Nursing Care. 8
th
Ed.6. Gloria D. Pickar and Amy Pickar-Abernethy. Dosage Calculations. 9
thEd.
PREPARED BY: APPROVED BY:
MRS. LOURADEL U. ALFONSO, MAN, RN DR. SOCORRO S. GASCO, RN, DMHRMClinical Instructor Dean, College of Nursing
1.
Review the anatomy
and physiology of the
respiratory system.
2.
Describe different
respiratory pathology.
3.
Describe thetherapeutic actions,
indications,
pharmacokinetics,
contraindications, most
common adverse
reactions, and
important drugdrug
interactions associated
with respiratory drugs.
4.
Outline the nursing
considerations in using
respiratory drugs.
1. Overview
a. Respiratory System
b. Respiratory Pathology
2. Drug Therapy
a. Bronchodilatorsb. Antiinflammatory Drugs for Asthma
c. Epectorants
d. Mucolytics
e. Antitussive Drugs
Mechanism of Action
- Therapeutic actions and indication
- Pharmacokinetics
- Contraindications and Cautions
- Adverse Effects
- Clinically important drug-drug
interaction
- Nursing Process
- Patient Teaching List
FINAL EXAMINATION
Oct. 16
1:303:00
Oct. 17
1:303:00
Oct. 20-25
MR. NICOLAS
MR. NICOLAS
-
8/10/2019 Revised Syllabus Pharmacology
15/15
15